A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni
Authors:
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 219, 109985
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim Animal Health R&D Animal Science and Welfare department, Research Laboratory and Clinical Analysis Laboratory
This publication has 9 references indexed in Scilit:
- Canine leptospirosis in Switzerland—A prospective cross-sectional study examining seroprevalence, risk factors and urinary shedding of pathogenic leptospiresPreventive Veterinary Medicine, 2017
- Efficacy of a multivalent DAPPi-Lmulti canine vaccine against mortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira experimental challengesVaccine Reports, 2016
- Comparison of Real-Time PCR Assays for Detection of Pathogenic Leptospira spp. in Blood and Identification of Variations in Target SequencesJournal of Clinical Microbiology, 2011
- Control of canine leptospirosis in Europe: time for a change?Veterinary Record, 2010
- Leptospira and leptospirosisVeterinary Microbiology, 2010
- Leptospirosis: a zoonotic disease of global importanceThe Lancet Infectious Diseases, 2003
- LeptospirosisClinical Microbiology Reviews, 2001
- Evidence of cross-protection within Leptospira interrogans in an experimental modelVaccine, 2000
- A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosisJournal of Medical Microbiology, 1986